SEP 9, 2026 · PHASE 2 TRIAL
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
ClinicalTrials.gov
This is an active Phase 2 interventional trial with no results posted; the registry record describes planned enrollment and primary outcome measures only, representing early-stage evaluation of a novel radiosensitizer in brain metastases.
Reported
Planned enrollment134
Study phasePhase 2
Primary outcome measureLocal Recurrence, assessed from enrollment…